Characteristics, experience, and treatment of schizophrenia in China by Phillips, Michael R.
chizophrenia is a condition that occurs in all
modern societies, but the prevalence, characteristics, sub-
jective experience, treatment, and course of the disorder
are,to some extent,molded by cultural and socioeconomic
conditions. There has been an explosion of new knowl-
edge about the biological determinants of schizophrenia
over the last two decades, but our understanding of the
interaction of biological,cultural,and socioeconomic fac-
tors in the development and course of the disorder has
changed little over the same period.To effectively use our
new knowledge about the biology of the disorder to
improve outcomes for patients and their families,we must
also understand how different socioeconomic environ-
ments affect the incidence, severity, and chronicity of the
disorder.Cross-cultural comparisons,though fraught with
a variety of methodological problems,can provide insights
that will help bridge this theoretical divide between the
biological and socioeconomic determinants of the disor-
der.As an example of the initial step that must be under-
taken before cross-cultural research can directly address
these issues, this paper describes schizophrenia in China
and highlights differences in the characteristics, experi-
ence,and treatment of the disorder between China and the
West that deserve further detailed study.
Characteristics of schizophrenia in China
Epidemiology
The Global Burden of Disease (GBD) study
1,2 used the
best available epidemiological data and sophisticated
projection methods to estimate the prevalence of schiz-
ophrenia in eight regions around the world. For China,
the estimated prevalence of schizophrenia in 1990 was
3.91 per 1000 population, so there were an estimated
4.43 million prevalent cases.This prevalence is less than
half that estimated for developed countries (8.98/1000),
but is similar to that estimated for India (3.36/1000).
Assessment of differences in the characteristics, experience,
and treatment of schizophrenia between China and the West
highlights the importance of the interaction of biological
and sociocultural factors in the onset and course of the dis-
order. China reports a much higher prevalence of schizo-
phrenia in urban areas than in rural areas and, surprisingly, a
higher prevalence in women than in men. Despite differ-
ences in the diagnostic criteria for schizophrenia, the pat-
tern of positive, negative, and cognitive symptoms is similar
to that seen in the West. Almost all medical treatment for
schizophrenia is provided from specialized psychiatric hos-
pitals, most of which are situated in urban centers. Antipsy-
chotic medication (often the generic clozapine) is the main-
stay of inpatient treatment. China developed a variety of
innovative community-based treatment models in the 1980s,
but the social and economic changes of the 1990s have made
it difficult to generalize these models. Overall, approximately
70% of the estimated 4.8 million persons with schizophrenia
in China do not receive regular treatment. 
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mentAs in all other regions of the world,there was a slightly
higher prevalence of schizophrenia in males in China
than in females (4.14/1000 versus 3.66/1000).The study
also estimated that only 30% of the individuals in China
suffering from schizophrenia received treatment in 1990
(compared with 80% in Western countries). Schizo-
phrenia is,therefore,an important public health problem
for China; it accounts for 1.8% of the total burden of
disease and is ranked as the 18th most important health
problem (in terms of disability-adjusted years life lost) in
the country.
The picture obtained from Chinese epidemiological
studies is somewhat different. Two World Health
Orgnaization (WHO)–supported epidemiological stud-
ies of mental illnesses have been conducted in China,
one in 1982
3,4 at 12 locations around the country and
one in 1993
5 at 7 locations around the country. These
studies randomly selected subjects 15 years of age and
older in urban and rural populations at each location
and obtained information about them from key infor-
mants (family members, local health care workers, and
local officials) using a brief screening instrument;a psy-
chiatrist then administered the Ninth Edition of the
Present State Examination (PSE-9)
6 to those who
screened positive and,on the basis of this examination,
determined the psychiatric diagnosis using ICD-9 (Inter-
national Classification of Diseases,Ninth Revision) crite-
ria. Projecting the reported point prevalence for schiz-
ophrenia in urban and rural areas to the corresponding
population groups in the country, the national point
prevalence for those aged 15 and older was 4.02 per
1000 in 1982 and 4.91 per 1000 in 1993.If one assumes a
zero prevalence in persons under 15 years of age (as is
done by the GBD study), the point prevalence for the
entire population would be 2.60 per 1000 in 1982 and
3.58 per 1000 in 1993. Based on these rates, there were
2.72 million prevalent cases in 1982 and 4.24 million
prevalent cases in 1993,a 56% increase in the absolute
number of cases in 11 years.This large increase is only
partly due to increased prevalence; the main reasons
were the rapid increase in the size of the population at
risk (the number of persons 15 years of age or older
increased from 675 million to 864 million) and the rapid
urbanization of the population (the proportion of the
population living in urban centers, where the preva-
lence is higher,increased from 21% to 28%).Applying
the 1993 results to the 1999 population, there were an
estimated 4.77 million prevalent cases in 1999.
The GBD study does not differentiate urban and rural
populations, so the Chinese studies provide valuable
information about the role of socioeconomic factors in
the course of the disorder. Both Chinese studies found
the point prevalence of schizophrenia in urban areas to
be significantly higher than that for rural areas: in 1982
the urban point prevalence for persons 15 years of age
or older was 6.07 per 1000 (116/19 116) versus a rural
prevalence of 3.42 per 1000 (65/19 020) (chi squared =
19.26, P<0.001) and in 1993 the urban point prevalence
was 6.71 per 1000 (59/8799) versus a rural prevalence
of 4.13 per 1000 (43/10 424) (chi squared =6.02,
P<0.025). There are several possible explanations for
these differences.
• These results could be seen as a within-country con-
firmation of the International Pilot Project on Schizo-
phrenia
7 findings that persons from less-developed
countries are more likely to have a full recovery from
a schizophrenic illness than persons from developed
countries. Overall, the rural areas in China are much
less developed than the urban areas,so a higher rate of
full recovery in less-developed areas would lead to
lower overall prevalence in the rural population
(assuming similar urban versus rural incidence).
• The tighter social networks and lower occupational
demands in rural areas could result in a lower inci-
dence of schizophrenia because fewer acute psychotic
episodes progress to a chronic illness.
• Given that most rural patients do not receive treat-
ment and most urban patients do receive treatment,
higher urban prevalence could occur because involve-
ment with the treatment system increases stigma, dis-
crimination,and chronic social dysfunction.
• There may be a higher rate of death among schizo-
phrenic patients in rural areas than in urban areas.
• There may be some degree of “social drift”of patients
to urban areas,but the two studies did not sample tem-
porary rural residents living in urban areas (the “float-
ing population”) and almost all persons continue to
live with their families after developing a serious men-
tal illness, so it is unlikely that social drift is a major
factor in the reported differences.
• The differences may also be due to methodological
problems in the studies. For example, the screening
method (using key informants) and the examination
method (using a translated version of the PSE-9) may
be less sensitive in rural areas where the level of illit-
eracy is much higher than in urban areas.
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Unlike the GBD estimates,both the 1982 and 1993 stud-
ies found that the point prevalence for schizophrenia
was much higher in women. In 1982, the point preva-
lence for women 15 years of age or older was 5.91 per
1000 (112/18 964) versus a male prevalence of 3.60 per
1000 (69/19 172) (chi squared = 10.74, P<0.005) and in
1993 the point prevalence for women was 6.65 per 1000
(64/9619) versus a male prevalence of 3.96 per 1000
(38/9604) (chi squared = 6.62, P<0.025). It is certainly
possible that these surprising gender-based differences
in rates are due to methodological problems.For exam-
ple, key informants may have been less likely to label
men’s behavior as “unusual” and men who were inter-
viewed may have been less willing than women to
acknowledge symptoms.However,Chinese psychiatrists
are convinced that this is a real difference,
8 so we must
also consider other possible explanations for the higher
rates in females:China-specific differences in the socio-
economic prospects of women and men (particularly in
the rural areas) could,potentially,produce differences in
the incidence and remission rates of the disorder by gen-
der.There are, moreover, other gender-specific charac-
teristics of schizophrenia in China that differ from those
in the West.For example,the long-held belief that males
have an earlier age of onset
9 is not confirmed in some
Chinese studies
10 (and is also questioned in some studies
in India
11).
Long-term follow-up studies of first-episode incident
cases of psychoses in urban and rural areas are needed to
fully understand the unique social epidemiology of schiz-
ophrenia in China. The advantage of conducting such
studies in China (versus multi-country studies) is that
they could reduce the variance due to “culture”and,thus,
address important questions about the relative roles of
biology and socioeconomic factors in the incidence and
course of psychotic disorders,including schizophrenia.
Chinese diagnostic criteria
The formal diagnostic criteria currently employed by
Chinese psychiatrists are those found in the Chinese
Classification of Mental Disorders, third edition, revised
(CCMD-3), which has just recently been published (in
April 2001) by the Chinese Society of Psychiatry.
12 This
diagnostic classification system, which has undergone
several revisions over the last few years,has similarities
to both the Diagnostic and Statistical Manual of Mental
Disorders (DSM) and ICD systems, but maintains its
unique elements based on the experience of Chinese
clinicians.
13The criteria for schizophrenia in the CCMD-3
have several differences when compared with those in
ICD-10 and DSM-IV.
• Symptomatic criteria. In the Chinese system at least
two out of the following nine groups of symptoms are
required during the acute phase of the illness:repeated
auditory hallucinations; thought disorder (loosening
of associations or poverty of thought); thought inser-
tion,withdrawal,or blocking;experiences of being con-
trolled or of thought broadcasting;primary delusions;
illogical thinking, symbolic thought, or neologisms;
inappropriate affect or marked apathy; catatonic or
bizarre behavior;and avolition.The inclusion of inap-
propriate affect and the subdivision of delusions into
three separate categories are two important differ-
ences between the Chinese and Western diagnostic
symptoms.
• Severity criteria. Unlike other systems, the CCMD-3
requires loss of insight during the active phase of the
illness and either significant social dysfunction or an
inability to communicate effectively.
• Duration criteria. Previous versions of the Chinese diag-
nostic criteria required 3 months of continuous active
symptoms (longer than the 1-month duration criteria of
ICD-10 and shorter than the 6-month duration criteria
of DSM-IV), but the new version of the Chinese crite-
ria now only requires 1 month of continuous active
symptoms, similar to the ICD-10 criteria.The Chinese
system does not consider prodromal or residual symp-
toms as part of the 1-month duration criteria.
• Diagnostic subtypes.The Chinese system includes “sim-
ple schizophrenia”among the subtypes;these patients
must have 2 years of continuous negative symptoms
and never have an episode of positive symptoms.
In the 1980s, there was widespread overdiagnosis of
schizophrenia in China
14,15; many patients who Western
clinicians would consider as suffering from affective dis-
orders were diagnosed as schizophrenic by their Chi-
nese counterparts. In the 1990s, the widespread pro-
mulgation of the formal Chinese diagnostic system
largely eliminated this problem,
16 though it still occurs
among poorly trained psychiatrists in smaller hospitals.
Despite the differences in the formal criteria, almost
all patients diagnosed by well-trained psychiatrists as
suffering from schizophrenia in China today would be
readily identifiable as suffering from schizophrenia by
Western clinicians.
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Symptomatology
One important question is the extent to which cultural
factors mold the expression of biologically based mental
disorders such as schizophrenia. Chinese clinicians did
not focus much attention on schizophrenic patients’ neg-
ative symptoms until the late 1980s and have only
recently started to pay attention to cognitive symptoms.
Assessment of Chinese inpatients’ symptoms
17 has found
that negative symptoms are largely independent of pos-
itive symptoms and that the interrelationship of posi-
tive and negative symptoms is quite similar to that
reported for Western patients. About 80% of Chinese
patients acutely admitted to psychiatric hospitals have
full remission of both positive and negative symptoms
during the standard 3-month admission.
18 There is little
research yet available on cognitive symptoms in Chi-
nese schizophrenic patients, but the available studies
19
suggest that the cognitive deficits among Chinese
patients are similar to those among Western patients.
This does not,however,mean that culture plays no role in
the patterning of symptoms in schizophrenia. The con-
tent of the delusions experienced by schizophrenic
patients in China has changed over time in parallel with
social changes.
20,21 Moreover, detailed assessment of 448
schizophrenic patients at admission using a Chinese ver-
sion of the Scale for Assessment of Positive Symptoms
22,23
found that Chinese patients are more likely than their
Western counterparts to experience erotomanic delusions
(9.4%) and delusions of control (20.8%), and are less
likely to experience thought broadcasting (7.4%),thought
withdrawal (5.1%), and thought insertion (4.5%).These
Chinese findings should be considered in the ongoing
debates about the diagnostic criteria for schizophrenia:
given the effect of cultural factors on the content of delu-
sions and the difficulty of assessing the “bizarreness” of
delusions cross-culturally,the wisdom of assigning greater
diagnostic significance to bizarre versus nonbizarre delu-
sions—as is done in DSM-IV—is in doubt.
The experience of schizophrenia in China
In China,as in many developing countries,the primary
responsibility for interpreting the bizarre symptoms
of schizophrenia and for managing a schizophrenic ill-
ness falls on the family, not on the individual, the
health care system, or the society as a whole. Psychi-
atric hospital beds are limited (1.2 per 10 000 popula-
tion), there are no half-way houses or other interme-
diate care facilities, and state authorities actively
return homeless persons to their families,so well over
90% of the 4.8 million persons currently suffering
from schizophrenia in China live with family mem-
bers.
24 (By contrast, an estimated 40% of the 1.2 mil-
lion schizophrenic patients in the USA live with fam-
ily members.
25) Traditionally,family members in China
assume responsibility for all the health care decisions
of a seriously ill individual; in the case of schizophre-
nia,the decision about when to seek care and where to
seek care is that of the family, not of the individual.
With the exception of serious forensic cases (eg, mur-
der or arson), there is no formal commitment proce-
dure for mentally ill patients;the family decides when
the patient is admitted (typically to a locked inpatient
facility) and has the power to discharge the patient at
any time.
Beliefs about causes and health care seeking
Very few patients with schizophrenia in China or their
family members consider biological factors important
causes of the problem.In a study in Suzhou and Siping
(cities in Jiangsu and Jilin provinces),245 family mem-
bers of 135 schizophrenic patients attributed 84% of
the cause of schizophrenia to social, interpersonal, and
psychological problems
26;even when prompted,none of
the respondents considered schizophrenia a “disease of
the brain.” Family members of well-educated urban
patients are more likely to employ internal attributions,
blaming the condition on some defect in the patient,
such as “personality problems”; family members from
rural areas are more likely to use external attributions,
blaming the condition on factors outside of the patient’s
control, such as spiritual or mystical forces.
The family’s hierarchy of resort to care providers is
determined by their beliefs about the causes of the prob-
lem and the availability and cost of different types of
providers. There are many possible choices: specialist
psychiatrists (almost all of whom are situated in urban
psychiatric hospitals),Western-style general physicians,
traditional Chinese medicine (TCM) physicians,herbal-
ists,acupuncturists,Buddhist monks,shamanistic healers,
and others.Chinese families are very pragmatic in their
utilization of services;they often try a variety of modal-
ities (either sequentially or concurrently) to find the
method that generates the most desirable outcome.
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Many rural residents start their care-seeking journey
with a local shaman who, they hope, will help explain
the bizarre thinking or behavior of their ill family mem-
ber:one study
27 of 300 schizophrenic patients treated in
the outpatient departments of six psychiatric hospitals in
central Hunan province found that 30% had first seen
shamans, and another study
28 from Hubei province
found that 74% (286/387) of patients from rural areas
admitted to a psychiatric hospital had first seen shamans.
Stigma
In the Chinese worldview,schizophrenic patients’ occa-
sional disruption of social order and their failure to act
in ways that promote social harmony are considered
serious transgressions of social norms.Given the public’s
fear of the mentally ill and of their potentially disruptive
effects, the community approach to the mentally ill is
primarily focused on control and only secondarily on
treatment.A 1999 study about attitudes toward the men-
tally ill in Beijing
29 found that over 60% of 254 randomly
selected community members believed that persons with
severe mental illnesses should not be allowed to marry
or have children,and about 40% believed that the men-
tally ill should not be allowed to live in the community,
return to work,or attend university.
These beliefs make it extremely difficult for persons
who suffer from a serious mental illness to obtain a job
or get married,and so most patients remain dependent
on family members for their entire life. Thus, it is not
surprising that family members often delay necessary
treatment for fear of being stigmatized and frequently
go to extreme lengths to prevent neighbors and other
acquaintances from discovering the family secret. In
most cases, the secret eventually comes out, resulting
in severe negative consequences for the individual and
the family. Combining data from a number of studies
undertaken in several locations around the country
from 1990 to 1998,84% (712/847) of family respondents
of schizophrenic patients reported that social stigma
affected the daily lives of their ill family member and
51% (434/847) reported that social stigma affected the
daily lives of healthy family members. In a Beijing
study
29 over 40% of the 211 schizophrenic patients inter-
viewed felt that their work unit discriminated against
them and that their neighbors looked down on them
and their family; 28% reported moving their homes to
avoid stigma.
Family burden
The economic and emotional burden of caring for a
schizophrenic family member in China is quite high.
Among family members of 456 admitted schizophrenic
patients from around the country,
22 65% reported that
the illness had a severe effect on healthy family mem-
bers’ emotional health over the prior 3 months, 46%
reported a severe effect on family finances, and 39%
reported a severe effect on healthy family members’
work.Assessment of family members with a revised Chi-
nese version of the Camberwell Family Interview
30,31
found that between 40% and 50% of coresident family
members of schizophrenic patients have high expressed
emotion at the time of the patient’s admission.(The abil-
ity of this measure to predict subsequent relapse in
China has not yet been fully assessed.) As would be
expected, families with a schizophrenic family member
in China have higher levels of conflict, lower cohesion,
and lower adaptability than matched control families.
32
Treatment and rehabilitation 
of schizophrenia in China
With a few exceptions,there are no psychiatric wards in
general hospitals and general physicians do not pro-
vide basic mental health services,and so almost all for-
mal treatment services provided for schizophrenic
patients are provided from specialized psychiatric hos-
pitals, most of which are situated in large urban cen-
ters.
33 Over the last decade, small psychiatric hospitals
have opened in the rural counties of large metropolitan
districts, such as Shanghai and Beijing and in a few
other locations, but the vast majority of the rural pop-
ulation—70% of the total population—still has no
access to mental health services or psychiatric medica-
tions,so family members must bring rural patients with
schizophrenia to the nearest city for psychiatric treat-
ment.In 1995,there were an estimated 917 psychiatric
hospitals in the country with a total of about 141 000
beds,
34 a national average of about 1.2 psychiatric beds
per 10 000 population. Approximately 75% of these
beds are occupied by patients suffering from schizo-
phrenia,one third in chronic care wards (with an aver-
age length of stay of over 1 year) and two thirds in
acute care wards.
The relative cost of psychiatric hospitalization has
increased rapidly over the last 15 years,more than twiceOral medication Proportion of all patients on Typical acute Cost for Proportion of per capita
antipsychotic medication taking treatment dose 1 month’s monthly income used to
each type of medication (%) (mg/day) supply (US $) pay for the medication (%)
1988 1994 1998 Urban Rural
N=1220† N=1543† N=1393†
Clozapine 19.8 29.5 33.8 400 3.40 6.2 15.5
Perphenazine 34.6 20.1 23.3 40 2.60 4.7 11.8
Chlorpromazine 24.3 17.3 12.9 500 1.54 2.8 7.0
Flupenthixol‡ 0.0 5.2 8.7 40 55.21 100.1 251.5
Haloperidol 10.1 7.5 7.5 30 1.92 3.5 8.8
Sulpride 0.2 5.8 6.7 1200 4.49 8.1 20.4
Risperidone‡ 0.0 0.0 4.4 4 52.54 95.3 239.3
as fast as the rise in incomes.
35 Less than 20% of schiz-
ophrenic patients have health insurance that covers
these costs, so hospitalization poses a heavy financial
burden for most families.The average 3-month psychi-
atric hospitalization for treatment of an acute episode
of schizophrenia now costs 6000 to 8000 renminbi
(US $725-US $969), which is more than the mean per
capita urban income and more than double the annual
mean per capita rural income (5425 renminbi and 2162
renminbi in 1998, respectively). Many families pay for
the first hospitalization in the hope that the treatment
will be curative;if the patient relapses they are reluctant
or unable to make the financial sacrifice a second time,
and so they may try to manage the patient at home.The
rapidly increasing costs have resulted in decreased
occupancy of psychiatric hospital beds around the coun-
try,which now stands at about 70%.One solution would
be to decrease the mean length of stay, but hospitals
are reluctant to do this because this would further
reduce revenues and because there are no community
services to provide the intense level of posthospitaliza-
tion care needed after a brief hospitalization.
Inpatient treatment
The cornerstone of the inpatient treatment of schizo-
phrenia in China,like elsewhere,is antipsychotic medica-
tion. Medication usage varies somewhat from region to
region and has changed over time; Table I shows the
antipsychotic usage at the Beijing Hui Long Guan Hos-
pital over the last decade. Almost all inpatients on
antipsychotic medication have a diagnosis of schizophre-
nia,and so the pattern of antipsychotic usage among inpa-
tients mirrors the pharmacological treatment of schizo-
phrenia. Despite reports that Asian patients require
significantly lower antipsychotic dosages to achieve the
same plasma concentrations as Caucasians,
36 the acute
treatment dosages administered to Chinese inpatients are
similar to or, in the case of the high-potency neurolep-
tics,somewhat higher than those used in the West.
The quality of the inpatient management of antipsy-
chotic medications varies widely,depending on the level
of training of the clinician;in some of the smaller hospi-
tals polypharmacy with multiple antipsychotics remains
a serious problem.
Clozapine, which has been produced generically in
China since 1978,is currently the most commonly used
antipsychotic medication at Beijing Hui Long Guan
Hospital (Table I), as it is in many other parts of the
country.
37 Initially only used in refractory patients,
clozapine has become increasingly popular in China
since the end of the 1980s, primarily because of good
clinical outcomes and low extrapyramidal side effects
(which many Chinese patients are unwilling to toler-
ate).It is now occasionally used as a first-line drug and
is fairly frequently given during the first admission of
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Table I. Most commonly used antipsychotic medications by inpatients at Beijing Hui Long Guan Hospital at three time periods,* typical acute
treatment dose, and monthly cost in Beijing in 1999. 
*Based on chart review of all inpatients on 28 September 1988 (N=1270), 1 June 1994 (N=1692), and 1 June 1998 (N=1505). 
†Polypharmacy was relatively uncommon: 8 of the 1220 patients (0.7%) taking antipsychotics in 1988 were taking two types of antipsychotics;
in 1994, 37 patients (2.4%) took two antipsychotics; and in 1998, 37 patients (2.7%) took two antipsychotics.
‡Imported medication.Schizophrenia in China - Phillips Dialogues in Clinical Neuroscience - Vol 3 . No.2 . 2001
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a patient if the first drug administered (usually per-
phenazine or chlorpromazine) is not rapidly effective
or has bothersome side effects.The most common rea-
sons for terminating treatment with clozapine are seda-
tion and hypersalivation. Blood monitoring for poten-
tial agranulocytosis was erratic in the early years of
use, but, by the beginning of the 1990s, monitoring
became more systematic; white blood counts with dif-
ferentials are now done on inpatients taking clozapine
weekly during the first 3 months of treatment and then
monthly thereafter.A review of 256 Chinese publica-
tions about clozapine from 1984 to 1995 identified 29
deaths due to clozapine and a combined rate of agran-
ulocytosis of 0.33% (25/7511).
38
Among the newer imported atypical medications only
risperidone and olanzapine are,as yet,available for clin-
ical use. Risperidone, unlike olanzapine, is covered by
government-based health insurance, and is thus being
used in a small proportion of patients. The extremely
high cost of the imported antipsychotics will severely
limit their use;clozapine is thus likely to remain one of
the most commonly used antipsychotic medications in
China for some time to come.
Other biological treatments are employed less fre-
quently.Acupuncture is occasionally used to treat psy-
chotic symptoms.
39 In most psychiatric hospitals,TCM
drugs are primarily used as adjunctive treatments to
improve the patient’s physical condition or to reduce
the intensity of the side effects of antipsychotic med-
ications, not as primary treatments for psychosis.
Insulin shock therapy was used fairly commonly until
the mid-1980s, but is now largely outdated.
40 Though
decreasing in use, Chinese clinicians still administer
electroconvulsive shock therapy (ECT) (usually with-
out anesthesia) to schizophrenic patients more fre-
quently (21% in one sample)
35 than their Western
counterparts; they consider ECT particularly helpful
for agitated patients and for hastening the recovery of
patients taking antipsychotic medication, a belief that
is also held by clinicians in other developing coun-
tries.
41
Almost all acute-care wards in Chinese psychiatric hos-
pitals are single-sex locked wards in which patients wear
hospital garb, so psychosocial interventions are impor-
tant in preventing the sensory deprivation that often
accompanies hospitalization. In some small, under-
staffed hospitals,acute-care patients spend most of their
time sitting in their rooms with nothing to do, while in
the larger well-staffed hospitals they participate in a
wide variety of activities, such as calligraphy classes,
“music therapy”
42 (listening to soothing music), and
“work therapy”(typically monotonous tasks).Similarly,
some chronic care wards are little more than ware-
houses for the severely mentally ill and the severely
mentally retarded, but the better chronic care wards
have an open-door policy, allow patients to wear their
own clothes,and provide a variety of structured activity
programs.
43-46 China has no occupational therapists or
psychiatric social workers and the small number of psy-
chologists working in psychiatric hospitals limit their
function to psychological testing (rather than provid-
ing clinical services);thus the psychosocial services that
are available to inpatients are thus provided primarily
by doctors and nurses.
Like everywhere else in the world, economic factors
influence the treatment schizophrenic patients receive
in China. Insured schizophrenic patients—primarily
urban residents who work for government-supported
industries—receive inpatient treatment 2.8 times more
frequently than uninsured schizophrenic patients; the
mean length of hospitalization of insured patients is
longer than that of uninsured patients;insured inpatients
are more likely to receive ancillary treatments such as
TCM drugs; and insured inpatients are less likely to
receive ECT.
35
Outpatient treatment
Almost all outpatient psychiatric services for schizo-
phrenic patients are provided in the outpatient depart-
ments of psychiatric hospitals: there are very few free-
standing community psychiatric clinics,the psychological
clinics that have opened in some general hospitals over
the last few years rarely provide services for schizo-
phrenic patients,and the number of private psychiatrists
(mostly physicians who have retired from the hospital
system) is extremely small.The primary service provided
in the outpatient clinics of psychiatric hospitals is med-
ication monitoring. There are no data available on the
pattern of antipsychotic usage in outpatient settings,but
it is probably quite similar to that for inpatients (Table I),
though the dosages used are somewhat lower. Most
patients are unwilling to take depot medications so their
use in outpatient settings is somewhat less than in the
West (the most commonly used depot medications are
haloperidol decanoate and fluphenazine decanoate).Clinical research
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Nonadherence is even more of a problem in China than
in the West;very few patients remain on medication for
more than 1 year after an initial admission.
As part of the new reform era (that started in 1978),
hospitals in China have been forced to become eco-
nomically self-sufficient;the state is no longer willing to
pay for services that are not profitable.This change has
decreased the willingness of hospital administrators to
expend personnel and resources to provide cost-effec-
tive (but nonprofitable) community services. Prior to
the mid-1980s most psychiatric hospitals provided exten-
sive outreach (“home-bed”) services to help schizo-
phrenic patients avert hospitalization, but the need to
become economically self-sufficient has forced hospi-
tals to cut back on services that reduce hospitalization
rates.Similarly,family therapy for schizophrenia
47,48 and
group psychoeducation for relatives of schizophrenic
patients
49 are cost-effective ways of reducing rehospital-
ization in China, but psychiatric hospitals (the only
source of the personnel who could provide these ser-
vices) are reluctant to employ family therapy methods in
their outpatient departments because this change would
reduce overall hospital revenues.
Community-based services
Social welfare services for disabled persons in China
experienced a renaissance during the 1980s, largely ini-
tiated and sustained by the efforts of the All China Dis-
abled Persons’ Federation under the direction of Deng
Pufang, Deng Xiaoping’s disabled son. A comprehen-
sive range of legislation during this period recognized
the extent of the problem of the disabled in the country,
established the rights of the disabled and the responsi-
bility of the state to provide for their care and employ-
ment,and set out a plan for their rehabilitation.As part
of this movement, psychiatric rehabilitation was trans-
formed from a low-status activity limited to “industrial
therapy” for chronically institutionalized patients to a
high status activity that provided mental health profes-
sionals with access to funding and support that were not
previously available.
50
In the absence of a culture-specific theory of psychiatric
rehabilitation,the indigenous models that evolved over
this period were based on vague notions about the ben-
efits of repetitive practice and social support; they
involved collective activities rather than individualized
assessment and skills-training.Most models were small-
scale,hospital-based experiments that never generalized
to the community because of a lack of trained personnel
in the community, limited funding, and lukewarm sup-
port from local officials.The community-based models
that did evolve focused on providing basic mental health
services for the severely mentally ill rather than on reha-
bilitation per se, but the use of the politically correct
“rehabilitation” rubric ensured a level of support that
would not otherwise have been available. Some small-
scale community-based models were quite successful,
particularly the comprehensive service network devel-
oped in the Zhengyang district of Shenyang (a large
industrial city in northern China).
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Two large-scale community-based models—the “Shang-
hai model”
52,53 and the “Yantai model”
54—were also suc-
cessful.The Yantai model provided basic mental health
services to the 6.3 million rural residents of the Yantai
district of Shandong province via a multi-tiered delivery
system. This included an advisory group in the central
urban psychiatric hospital, community psychiatrists in
small county-level psychiatric hospitals who trained
nonpsychiatric physicians to provide outpatient psychi-
atric services in township-level general hospitals, and
village paramedics (“village doctors”) who supervised
patients in the community. The Shanghai model pro-
vided an integrated support network for persons with
chronic mental illnesses (primarily schizophrenia)
among Shanghai’s 13 million residents that combined:
(i) community follow-up of psychiatric outpatients at
primary-level general hospitals; (ii) the innovative
“guardianship networks” operated by nonprofessional
volunteers (usually retired workers,patients’ neighbors,
and community officials) who supervised the care of
patients in the community; and (iii) work therapy sta-
tions (ie, sheltered workshops) that provided an occu-
pation to patients who had a limited capacity to work.
The All China Disabled Persons’ Federation promoted
the generalization of a slightly revised version of the
Shanghai model to 64 sites around the country as part of
their Eighth Five-Year National Development Plan
(1991-1995) and to 200 urban and rural communities as
part of their Ninth Five-Year National Development
Plan (1996-2000).However,sustaining and generalizing
these excellent models of care delivery in the 1990s has
proven difficult, largely because the economic reforms
have changed the socioeconomic factors that made the
models possible in the first place. Community volun-
teers are much harder to find because more retired per-Schizophrenia in China - Phillips Dialogues in Clinical Neuroscience - Vol 3 . No.2 . 2001
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sons are now involved in income-generating activities,so
guardianship networks are difficult to develop and main-
tain. Many factories are laying off workers and trying
to improve their efficiency, and so they no longer have
piece-work to give to the sheltered workshops; without
revenue producing work, many workshops have had to
close because they are no longer economically viable.
Moreover,many local governments are trying to reduce
their expenditures,and are thus reluctant to support any
expansion of health and welfare services.
Overall, community-based services for schizophrenic
patients are still primarily limited to the large cities and,
even there, the services are patchy; medium-size cities
rarely have more than token services; and throughout
most of the countryside there are no mental health ser-
vices whatsoever.
Challenges 
and opportunities
Schizophrenia is a serious public health problem for
China that the mental health care system and the social
welfare system are not, as yet, adequately addressing.
The socioeconomic factors that are influencing the
development of health services in China are quite dif-
ferent from those in other countries, and so the chal-
lenges and opportunities for providing comprehensive
services to persons suffering from schizophrenia are, to
some extent,unique.
The challenges
• There are no psychiatric services in most of China's
vast countryside,and so 70% of the estimated 4.8 mil-
lion schizophrenic patients in the country do not
receive treatment.
• General physicians and other health workers are
unable (and often unwilling) to provide basic psychi-
atric services because they have little or no training in
mental health, and so almost all professional services
for schizophrenic patients are provided from urban
psychiatric hospitals.
• Many schizophrenic patients and their family mem-
bers cannot afford inpatient care or the new antipsy-
chotic medications.
• The current economic incentives require psychiatric
hospitals to maintain high occupancy, and so there is
no motivation to provide high-quality outpatient or
community-based care that would reduce hospitaliza-
tion rates.
• There are no occupational therapists,psychiatric social
workers, or community psychiatric nurses, and so the
community-based services that are available are pri-
marily provided by nonprofessionals with little or no
training in mental health.
• Lack of knowledge about mental illnesses and the
stigmatization of the mentally ill limits use of the ser-
vices that are available and greatly magnifies the bur-
den experienced by schizophrenic patients and their
family members.
• There is no organized family movement that could
lobby for the provision of family-based services.
The opportunities 
• The rapid increases in the costs of inpatient care are
making community-based alternatives to inpatient
care more and more cost-effective.
• The Ministry of Health and the powerful All China
Disabled Persons’ Federation are actively promoting
the development of high-quality community-based
mental health services.
• Over 90% of schizophrenic patients in China live with
their families, and so family members are eager to
receive education about the illness and they respond
well to interventions that include social support ser-
vices and family groups.
• Public awareness of the importance of psychological
factors to overall health is gradually increasing, par-
ticularly in urban areas.
Conclusion
As China moves forward in the development of its men-
tal health care system,it will have many lessons to learn
from the West.However,the West also has many lessons
to learn from China.Detailed,long-term assessments of
the onset and course of schizophrenia in urban and rural
China—with a particular emphasis on those aspects that
are different from the West—will help clarify the com-
plex interaction between biological and socioeconomic
factors. These important theoretical issues must be
resolved before we can translate the new biological find-
ings into better outcomes for the large numbers of
untreated or poorly treated patients suffering from
schizophrenia.❑Clinical research
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